Want to see AU:GSS full AI Analyst Report?
Total Valuation
Genetic Signatures Ltd. has a market cap or net worth of AU$17.04M. The enterprise value is -AU$6.57.
Market CapAU$17.04M
Enterprise Value-AU$6.57
Share Statistics
Genetic Signatures Ltd. has 227,138,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding227,138,820
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Genetic Signatures Ltd.’s return on equity (ROE) is -0.39 and return on invested capital (ROIC) is -37.25%.
Return on Equity (ROE)-0.39
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-37.25%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee123.53K
Profits Per Employee-119.71K
Employee Count117
Asset Turnover0.38
Inventory Turnover4.38
Valuation Ratios
The current PE Ratio of Genetic Signatures Ltd. is ―. Genetic Signatures Ltd.’s PEG ratio is 0.04.
PE Ratio―
PS Ratio1.05
PB Ratio0.43
Price to Fair Value0.43
Price to FCF-1.73
Price to Operating Cash Flow-2.28
PEG Ratio0.04
Income Statement
In the last 12 months, Genetic Signatures Ltd. had revenue of 14.45M and earned -14.01M in profits. Earnings per share was -0.06.
Revenue14.45M
Gross Profit-12.72M
Operating Income-17.74M
Pretax Income-18.50M
Net Income-14.01M
EBITDA-15.68M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was -7.77M and capital expenditures -1.05M, giving a free cash flow of -8.82M billion.
Operating Cash Flow-7.77M
Free Cash Flow-8.82M
Free Cash Flow per Share-0.04
Dividends & Yields
Genetic Signatures Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change-70.57%
50-Day Moving Average0.07
200-Day Moving Average0.11
Relative Strength Index (RSI)54.66
Average Volume (3m)459.90K
Important Dates
Genetic Signatures Ltd. upcoming earnings date is Feb 16, 2027, TBA (Confirmed).
Last Earnings DateAug 24, 2026
Next Earnings DateFeb 16, 2027
Ex-Dividend Date―
Financial Position
Genetic Signatures Ltd. as a current ratio of 13.10, with Debt / Equity ratio of 0.87%
Current Ratio13.10
Quick Ratio10.80
Debt to Market Cap0.02
Net Debt to EBITDA0.56
Interest Coverage Ratio-385.72
Taxes
In the past 12 months, Genetic Signatures Ltd. has paid -4.49M in taxes.
Income Tax-4.49M
Effective Tax Rate0.24
Enterprise Valuation
Genetic Signatures Ltd. EV to EBITDA ratio is -0.41, with an EV/FCF ratio of -0.73.
EV to Sales0.45
EV to EBITDA-0.41
EV to Free Cash Flow-0.73
EV to Operating Cash Flow-0.83
Balance Sheet
Genetic Signatures Ltd. has AU$22.09M in cash and marketable securities with AU$310.00K in debt, giving a net cash position of AU$21.79M billion.
Cash & Marketable SecuritiesAU$22.09M
Total DebtAU$310.00K
Net CashAU$21.79M
Net Cash Per ShareAU$0.10
Tangible Book Value Per ShareAU$0.16
Margins
Gross margin is -88.02%, with operating margin of -122.76%, and net profit margin of -96.91%.
Gross Margin-88.02%
Operating Margin-122.76%
Pretax Margin-127.98%
Net Profit Margin-96.91%
EBITDA Margin-108.49%
EBIT Margin-122.76%
Analyst Forecast
The average price target for Genetic Signatures Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-9.10%
EPS Growth Forecast31.75%